In contrast, the down-regulation of ESR1 is suggestive of better OS in acute myeloid leukemia (LAML), brain lower grade glioma (LGG), lung squamous cell carcinoma (LUSC) and stomach adenocarcinoma (STAD). Here, ESR1 is linked to gastric adenocarcinoma.